Energy Dept. Faces Battle on SSC

WASHINGTON-A $363 million request for the Superconducting Supercollider, part of the Department of Energy's proposed research budget, faces an uncertain future in Congress. DOE officials will face some tough questions on the SSC at hearings later this week, said Edd Nolan, an aide to Rep. Tom Bevill (D-Ala.), chairman of the House appropriations subcommittee on energy and water. Bevill "doesn't know where the money is going to come from," said Nolan. The new proposal would consume one-fift

Written byDaniel Charles
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WASHINGTON-A $363 million request for the Superconducting Supercollider, part of the Department of Energy's proposed research budget, faces an uncertain future in Congress.

DOE officials will face some tough questions on the SSC at hearings later this week, said Edd Nolan, an aide to Rep. Tom Bevill (D-Ala.), chairman of the House appropriations subcommittee on energy and water. Bevill "doesn't know where the money is going to come from," said Nolan.

The new proposal would consume one-fifth of the agency's budget for basic sciences research. Last year Congress approved $25 million for the SSC, but cut out $10 million sought for construction. A similar decision this year would leave $64 million for research.

DOE's existing laboratories and new research facilities received favored treatment in the 1989 budget. Leaving aside the SSC, funding for research facilities is projected to increase by 11 percent, from $550 million to $610 million. The cost ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies